Cerity Partners
ALNY icon

Cerity Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cerity Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.7M Sell
20,256
-4,322
-18% -$1.47M 0.01% 883
2025
Q4 		$9.77M Sell
24,578
-2,851
-10% -$1.26M 0.01% 645
2025
Q3 		$12.5M Buy
27,429
+17,316
+171% +$7.05M 0.02% 497
2025
Q2 		$3.3M Sell
10,113
-4,529
-31% -$1.25M 0.01% 997
2025
Q1 		$3.95M Buy
14,642
+1,117
+8% +$287K 0.01% 823
2024
Q4 		$3.24M Buy
13,525
+506
+4% +$133K 0.01% 895
2024
Q3 		$3.58M Buy
13,019
+7,445
+134% +$1.94M 0.01% 848
2024
Q2 		$1.35M Buy
5,574
+2,382
+75% +$376K ﹤0.01% 1094
2024
Q1 		$477K Buy
+3,192
New +$532K ﹤0.01% 1622
2023
Q1 		– Sell
-1,070
Closed -$254K – 1850
2022
Q4 		$254K Buy
+1,070
New +$228K ﹤0.01% 1219

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return